Anthony P. Mack is Chief Executive Officer of Virpax Pharmaceuticals, Inc.. Currently has a direct ownership of 252,562 shares of VRPX, which is worth approximately $121,229. The most recent transaction as insider was on May 18, 2022, when has been sold 75,750 shares (Common Stock, $0.00001 par value) at a price of $1.34 per share, resulting in proceeds of $101,505. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 253K
0% 3M change
0% 12M change
Total Value Held $121,229

Anthony P. Mack Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2022
BUY
Open market or private purchase
$101,505 $1.34 p/Share
75,750 Added 23.07%
252,562 Common Stock, $0.00001...
Nov 18 2021
BUY
Open market or private purchase
$100,249 $3.99 p/Share
25,125 Added 12.44%
176,812 Common Stock, $0.00001...
APM

Anthony P. Mack

Chief Executive Officer
Berwyn, PA

Track Institutional and Insider Activities on VRPX

Follow Virpax Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRPX shares.

Notify only if

Insider Trading

Get notified when an Virpax Pharmaceuticals, Inc. insider buys or sells VRPX shares.

Notify only if

News

Receive news related to Virpax Pharmaceuticals, Inc.

Track Activities on VRPX